Glimisave M 3 Tablet PR
By Glimisave M
Rx
15 Tablet PR in a Strip

Composition
Glimepiride(3mg) + Metformin(500mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
October, 2027

liver
When using Glimisave M 3 Tablet PR, it is essential to exercise caution if you have a history of liver diseases or conditions. Patients with liver disease may require a dose adjustment when taking Glimisave M 3 Tablet PR. It is advisable to start the medication at a low dose for individuals with mild to moderate liver disease. Patients with severe liver disease are advised not to use Glimisave M 3 Tablet PR without consulting their healthcare provider. Always consult your doctor to discuss the appropriate usage of Glimisave M 3 Tablet PR if you have liver issues.

kidney
Use Glimisave M 3 Tablet PR cautiously if you have kidney disease; dose adjustment may be necessary. Not recommended for severe kidney disease. Monitor kidney function regularly while on treatment, especially with a history of kidney conditions.

alcohol
It is not safe to drink alcohol while taking Glimisave M 3 Tablet PR, as it can lead to increased risk of lactic acidosis. It is advised to avoid alcohol consumption with this medication.

driving
When taking Glimisave M 3 Tablet PR, it's important to be cautious when driving. Low or high blood sugar levels can affect driving ability, so avoid driving if you experience these symptoms. Additionally, the tablet may reduce alertness in some individuals, so only drive if you feel fully alert after taking it.

pregnancy
Glimisave M 3 Tablet PR is not recommended for pregnant women as it may harm the unborn baby. Limited studies suggest potential risks. Please consult a doctor if pregnant or planning pregnancy.

breastfeeding
Caution Glimisave M 3 Tablet PR is not recommended during breastfeeding as it may be harmful to the baby, causing potential toxicity and adverse effects. It is advised to consult a healthcare professional before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹215.89
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024